Tag Archives: Genmab A/S

July’s IPO action in health sector foreshadows record month of pricings.

The second week of July continued the stampede among healthcare startups and seasoned players in search of new funding from Wall Street and, in one case, the Hong Kong exchange…. Read more »

Europe, sans Basel, Copenhagen and Paris, taking on the US biotech titans.

The News: Since its birthday back in 1776, America has seen itself as the land of the new–and Europe as a landmass caught in the past. Nowhere is that truer… Read more »

From across the pond, 2017’s brightest European biotech stars; perhaps under US’s radar, but still ready to soar?

Many said good riddance to 2016 for biotech and pharma; things could only get better this year–and the European industry didn’t disappoint, says Labiotech.eu, the quintessential industry observer and news… Read more »